Genetic polymorphisms of XRCC7 6721G>T were associated with an increased risk of glioma [22], bladder cancer [28], and SLE [30], while other studies reported that there were no significant associations between this polymorphism and risk of renal cell carcinoma and differentiated thyroid cancer [24, 29]. This evidence concerns the gene PRKDC and glioma.